These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 432125

  • 21. Drug metabolism and liver disease in India.
    Narang AP, Kaur U, Bambery P.
    Drug Metab Rev; 1991; 23(1-2):65-81. PubMed ID: 1868778
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Side effects of drugs--predictable hazards for patients with liver disease].
    Baumgarten R.
    Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
    [No Abstract] [Full Text] [Related]

  • 24. [Drug therapy in liver diseases: problems in intensive care].
    Follath F.
    Schweiz Med Wochenschr; 1986 Apr 26; 116(17):549-52. PubMed ID: 3715434
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Terminal half-lives of drugs studied in patients with hepatic diseases.
    Closson RG.
    Am J Hosp Pharm; 1977 May 26; 34(5):520-4. PubMed ID: 326043
    [Abstract] [Full Text] [Related]

  • 27. [Metabolism and toxicity of drugs used during pregnancy and perinatal period].
    Prandota J, Iwańczak F.
    Pediatr Pol; 1980 Apr 26; 55(4):517-24. PubMed ID: 6997824
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Rational posology and drug dosage].
    Riant P, Albengres E, Barre J, Tillement JP.
    Ann Biol Clin (Paris); 1986 Apr 26; 44(1):15-24. PubMed ID: 3518550
    [Abstract] [Full Text] [Related]

  • 30. [Characteristics of drug therapy in kidney and liver insufficiency, in infancy and old age, during pregnancy and lactation].
    Rameis H.
    Wien Med Wochenschr; 1983 Mar 31; 133(6):141-51. PubMed ID: 6858179
    [No Abstract] [Full Text] [Related]

  • 31. [Presystemic elimination and biological availability of drugs].
    Klotz U.
    Med Lab (Stuttg); 1981 Mar 31; 34(7-8):171-6. PubMed ID: 7311931
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Effects of drug distribution, entero-hepatic cycle, bioavailability].
    Bailly-Salins F, Woronoff-Lemsi MC.
    Soins; 1998 Apr 31; (624):41-3. PubMed ID: 9633463
    [No Abstract] [Full Text] [Related]

  • 34. [Recent findings on the hepatotoxicity of drugs].
    Altomare E, Vendemiale G, Stufano N, Di Monte D, Procacci V, Albano O.
    Recenti Prog Med; 1985 Nov 31; 76(11):598-605. PubMed ID: 3912875
    [No Abstract] [Full Text] [Related]

  • 35. [Effects of liver disease on drug pharmacokinetics].
    Su CY.
    Sheng Li Ke Xue Jin Zhan; 1983 Jul 31; 14(3):238-42. PubMed ID: 6648457
    [No Abstract] [Full Text] [Related]

  • 36. Drug disposition in liver disease.
    Fruncillo RJ.
    Am Fam Physician; 1982 Dec 31; 26(6):167-9. PubMed ID: 7148640
    [No Abstract] [Full Text] [Related]

  • 37. Safe prescribing in liver disease.
    Br Med J; 1973 Apr 28; 2(5860):193-4. PubMed ID: 4700003
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation.
    Gilmore IT, Hofmann AF.
    Gastroenterology; 1980 Jan 28; 78(1):177-9. PubMed ID: 7350025
    [No Abstract] [Full Text] [Related]

  • 40. Fetal and neonatal pharmacology.
    Yaffe SJ.
    Clin Perinatol; 1974 Mar 28; 1(1):39-45. PubMed ID: 4470047
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.